Core Viewpoint - Philip Morris International (PMI) is transitioning towards a smoke-free future by diversifying its product portfolio beyond traditional tobacco and nicotine products, focusing on innovative smoke-free alternatives [1] Product Portfolio - PMI's current offerings include cigarettes and smoke-free products such as heat-not-burn, nicotine pouches, and e-vapor products [1] - As of June 30, 2025, PMI estimates that over 41 million legal-age consumers globally are using its smoke-free products, many of whom have reduced or stopped cigarette consumption [1] - The smoke-free segment contributed to 41% of PMI's total net revenues in the first nine months of 2025 [1] Investment and Development - Since 2008, PMI has invested over $14 billion in the development and commercialization of smoke-free products aimed at adult smokers [1] - The company has established scientific assessment capabilities in areas such as pre-clinical systems toxicology, clinical and behavioral research, and post-market studies [1] Regulatory Approvals - The U.S. Food and Drug Administration (FDA) has authorized the marketing of Swedish Match's General snus and ZYN nicotine pouches, as well as versions of PMI's IQOS devices and consumables, marking the first-ever authorizations in their categories [1] - IQOS devices and General snus have also received the first-ever Modified Risk Tobacco Product authorizations from the FDA [1] Future Ambitions - PMI aims to leverage its expertise in life sciences to expand into wellness and healthcare sectors, focusing on enhancing life through seamless health experiences [1]

Core Insights - Altria Group's stock price fell over 5% following significant market share losses in the cigarette sector [1] Market Performance - Altria's domestic cigarette shipment volumes decreased by 7.9% in Q4, reflecting a continued decline in smoking rates in the U.S. [2] - The retail market share of Altria's Marlboro brand dropped to 39.8%, a year-over-year decline of 1.5 percentage points [2] Product Segments - Altria's oral tobacco products also experienced a decline, with shipment volumes falling by 6.3% due to market share losses [3] - The on! brand's share in the nicotine pouch category decreased by 5.3 percentage points to 13.4% [3] Financial Performance - Altria's revenues, net of excise taxes, slightly declined by less than 1% to $5.1 billion, with price increases offsetting lower shipment volumes [4] - Adjusted earnings per share remained flat at $1.30, supported by stock buybacks [4] - Management projects a growth in full-year adjusted earnings of 2.5% to 5.5% in 2026, estimating a range of $5.56 to $5.72 per share, aided by cost-cutting measures [4]

Software Sector Performance - The software sector is experiencing a significant sell-off, with the iShares Expanded Tech-Software ETF (IGV) down over 5%, marking a decline not seen since tariff Liberation Day [6] - Major tech indices, including the Nasdaq, are also affected, alongside declines in bitcoin, gold, and silver [6] Microsoft and ServiceNow - Microsoft (MSFT) shares have dropped approximately 12%, potentially marking the seventh-worst decline in its history, despite reporting solid quarterly results [7] - Analysts indicate that the focus has shifted from demand to capacity timing and allocation, with a 66% year-over-year increase in capital expenditures raising investor concerns about the effectiveness of this investment in driving Azure growth [7] - ServiceNow (NOW) has seen a decline of over 10% despite reporting a 21.5% growth in subscription revenue, which analysts believe does not indicate acceleration [8] Other Software Companies - Other companies such as Atlassian (TEAM), Salesforce (CRM), Workday (WDAY), and DataDog (DOG) are also experiencing significant declines [8] Caterpillar's Performance - Caterpillar (CAT) reported fourth-quarter sales of $19.1 billion, exceeding the consensus estimate of $17.76 billion, with adjusted EPS of $5.16, surpassing the expected $4.71 [9] - The power and energy sales segment increased by 23% to $9.4 billion, with power generation revenue rising 44% to $3.24 billion, driven by demand related to data centers and AI applications [10] Altria and Joby Aviation - Altria (MO) is facing pressure after slightly missing profit estimates in Q4, while targeting mid-single-digit annual dividend-per-share growth through 2028 [11] - Joby Aviation (JOBY) is declining after announcing a $600 million offering of convertible senior notes and selling approximately 52.9 million shares of common stock at $11.35 per share [11] Barry Diller's Interest in CNN - Barry Diller has expressed interest in acquiring CNN and approached Warner Bros. Discovery (WBD) regarding a deal last year, although no serious action was taken on his approach [12][13]

Core Insights - Altria Group Inc. reported fourth-quarter 2025 results with top-line revenue exceeding estimates but declining year over year, while bottom-line earnings missed expectations and remained flat compared to the previous year [1] Financial Performance - Adjusted earnings per share (EPS) for the fourth quarter were $1.30, flat year over year, and below the Zacks Consensus Estimate of $1.31, influenced by a lower adjusted tax rate and reduced share count, offset by lower adjusted operating companies' income (OCI) [2] - Net revenues totaled $5,846 million, a decline of 2.1% year over year, primarily due to decreased revenues in the smokeable products segment, although it surpassed the consensus estimate of $5,002 million [3] Segment Analysis - **Smokeable Products**: Net revenues fell 2.7% year over year to $5,119 million, driven by reduced shipment volume and increased promotional investments, partially offset by higher pricing. Revenues net of excise taxes decreased 1.1% [4] - Domestic cigarette shipment volumes dropped 7.9%, attributed to industry decline and trade inventory movements, while cigar shipment volumes increased by 4.2% [5] - Adjusted OCI in this segment decreased 2.4% to $2,643 million, impacted by reduced shipment volume and higher costs, with adjusted OCI margins falling 0.8 percentage points to 60.4% [6] - **Oral Tobacco Products**: Net revenues increased 2% to $706 million, driven by higher pricing, although shipment volumes declined by 6.3% due to retail share losses and trade inventory movements [7][8] - Adjusted OCI in this segment decreased 4.6%, influenced by elevated SG&A costs and a decline in shipment volumes, with adjusted OCI margins decreasing 5 percentage points to 64.5% [9] Capital Management - Altria ended the quarter with cash and cash equivalents of $4,474 million and long-term debt of $24,140 million, alongside a total stockholders' deficit of $3,502 million [10] - In Q4 2025, the company repurchased 4.8 million shares for $288 million, and for the full year, it repurchased 17.1 million shares totaling $1 billion, with $1 billion remaining under the share repurchase program [11] Future Outlook - For 2026, Altria expects adjusted EPS in the range of $5.56 to $5.72, indicating year-over-year growth of 2.5% to 5.5% from a base of $5.42 in 2025, with growth anticipated to be weighted towards the second half of the year [12] - The company projects an adjusted effective tax rate of 22.5% to 23.5%, capital expenditures of $300-$375 million, and depreciation and amortization expenses of approximately $225 million [13]

Core Insights - Altria reported revenue of $5.08 billion for the quarter ended December 2025, showing a year-over-year decline of 0.5% and an EPS of $1.30, slightly up from $1.29 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $5 billion, resulting in a surprise of +1.54%, while the EPS fell short of the consensus estimate of $1.32, leading to a surprise of -1.13% [1] Financial Performance Metrics - Revenue from Oral Tobacco Products was $682 million, surpassing the estimated $673.99 million, reflecting a year-over-year increase of +2.9% [4] - Revenue from Smokeable Products was $4.38 billion, exceeding the average estimate of $4.29 billion, but showing a year-over-year decline of -1.1% [4] - Adjusted Operating Companies Income (OCI) for Smokeable Products was reported at $2.64 billion, slightly below the average estimate of $2.67 billion [4] - Reported OCI for Oral Tobacco Products was $438 million, compared to the average estimate of $466.35 million from two analysts [4] Stock Performance - Altria's shares have returned +9.5% over the past month, outperforming the Zacks S&P 500 composite, which saw a change of +0.8% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Core Viewpoint - Altria's shares declined after reporting flat earnings due to falling cigarette sales and increased competition from unauthorized disposable e-cigarettes [1][3] Financial Performance - Altria's fourth-quarter revenue decreased by 2% to $5.8 billion, primarily due to lower cigarette sales [2] - The adjusted net income was reported at $1.30 per share, which was below Wall Street's expectations of $1.32 per share [3] Market Dynamics - The company faces challenges from unauthorized disposable e-cigarettes that are cheaper and available in various flavors, impacting traditional cigarette sales [2] - Altria's on! pouches market share fell to approximately 13%, down about 5 percentage points from the previous year [5] Competitive Landscape - The U.S. pouch market is led by Zyn from Philip Morris International, which holds over two-thirds of the market share [6] - Altria is experiencing pricing competition from Philip Morris, including promotional sales for Zyn [6] Strategic Initiatives - Altria is working on diversifying its business into next-generation products like e-cigarettes and nicotine pouches, although it is not a market leader in these areas [4] - The company plans to implement pricing strategies and introductory promotions as it expands its nicotine pouches nationally later this year [6][7]

Financial Data and Key Metrics Changes - In 2025, adjusted diluted earnings per share grew by 4.4% and the company returned $8 billion to shareholders through dividends and share repurchases combined [4] - The smokable product segment delivered over $11 billion in adjusted operating income (OCI) for the full year, expanding adjusted OCI margins by 1.8 percentage points to 63.4% [18] - For the fourth quarter, adjusted OCI declined by 2.4%, and adjusted OCI margins contracted by 0.8 percentage points to 60.4% [18] Business Line Data and Key Metrics Changes - Domestic cigarette volumes declined by 7.9% in the fourth quarter and 10% for the full year [18] - The oral tobacco product segment retail share was 29.6% for the fourth quarter and 31.9% for the full year [23] - Total segment reported shipment volume decreased 6.3% for the fourth quarter and 5.5% for the full year [22] Market Data and Key Metrics Changes - The estimated number of adult consumers in the e-vapor and oral tobacco categories grew to almost 30 million, reflecting the potential for tobacco harm reduction in the U.S. [7] - The e-vapor category grew approximately 15% in 2025, with illicit products representing approximately 70% of the category [8] - The nicotine pouch category drove overall oral tobacco volume growth, which increased an estimated 14% over the past six months [10] Company Strategy and Development Direction - The company is focused on advancing its smoke-free portfolio and building a portfolio of FDA-authorized smoke-free products for adult smokers [16] - Strategic collaborations, such as with KT&G, aim to enhance international modern oral and U.S. non-nicotine growth [5] - The company plans to maintain a measured approach to investments in e-vapor until the regulatory framework is functioning effectively [10] Management's Comments on Operating Environment and Future Outlook - Management noted that the growth in disposable vapers moderated in 2025 compared to the prior year, indicating a potential stabilization in the market [9] - The company expects to deliver 2026 full year adjusted diluted EPS in a range of $5.56-$5.72, reflecting a growth rate of 2.5%-5.5% from a $5.42 base in 2025 [16] - Management expressed confidence in the company's strategy and the opportunities ahead, emphasizing the importance of responsible participation in the e-vapor category [17] Other Important Information - The company recorded non-cash impairment charges of $1.3 billion related to e-vapor definite-lived intangible assets and goodwill [23] - The company paid $7 billion in dividends in 2025, marking its 60th increase in the last 56 years [25] - The total debt-to-EBITDA ratio as of December 31 was 2x, in line with the company's target [25] Q&A Session Summary Question: Can you provide any color on the scope of the import/export program? - Management indicated that the program involves both upfront investments and the opportunity for duty drawback, setting up manufacturing capabilities for international markets [32] Question: Is the elevated CapEx associated with the investments for import/export? - Management confirmed that the primary driver of the increase in CapEx is the investments for the import/export business, but they did not provide guidance for future CapEx [34] Question: How is the promotional strategy behind Basic affecting net price realization? - Management clarified that the strategy around Basic is independent of the duty drawback and is aimed at capturing consumers under economic pressure [41] Question: Are there any signs of increased smoking incidence among younger legal-aged nicotine users? - Management stated that there are no trends indicating increased incidence among younger cohorts, emphasizing the need for expedited authorization of smoke-free products [52] Question: What is the pricing strategy for on! PLUS? - Management believes that on! PLUS is a differentiated product that commands a premium in the marketplace, with various introductory price promotions planned [53]

Financial Data and Key Metrics Changes - In 2025, adjusted diluted earnings per share grew by 4.4% and the company returned $8 billion to shareholders through dividends and share repurchases combined [4] - The smokable product segment delivered over $11 billion in adjusted operating income (OCI) for the full year, expanding adjusted OCI margins by 1.8 percentage points to 63.4% [18] - For the fourth quarter, adjusted OCI declined by 2.4%, and adjusted OCI margins contracted by 0.8 percentage points to 60.4% [18] Business Line Data and Key Metrics Changes - Domestic cigarette volumes declined by 7.9% in the fourth quarter and 10% for the full year [18] - The oral tobacco product segment reported a shipment volume decrease of 6.3% for the fourth quarter and 5.5% for the full year [22] - Nicotine pouches drove overall oral tobacco volume growth, which increased an estimated 14% over the past six months [10] Market Data and Key Metrics Changes - The estimated number of adult consumers in the e-vapor and oral tobacco categories grew to almost 30 million, reflecting the potential for tobacco harm reduction in the U.S. [7] - The e-vapor category grew approximately 15% in 2025, with illicit products representing approximately 70% of the category [8] - The nicotine pouch category saw a retail share of 29.6% for the fourth quarter and 31.9% for the full year [23] Company Strategy and Development Direction - The company is focused on advancing its smoke-free portfolio and building a portfolio of FDA-authorized smoke-free products for adult smokers [16] - Strategic collaborations, such as with KT&G, aim to enhance international modern oral and U.S. non-nicotine growth [5] - The company plans to maintain a measured approach to investments in e-vapor until the regulatory framework is functioning effectively [10] Management's Comments on Operating Environment and Future Outlook - Management noted that the growth in disposable vapers moderated in 2025, with a 10% increase compared to over 40% in 2024 [9] - The company expects to deliver 2026 full year adjusted diluted EPS in a range of $5.56-$5.72, representing a growth rate of 2.5%-5.5% from a $5.42 base in 2025 [16] - Management expressed confidence in the company's strategy and the opportunities ahead, emphasizing the importance of responsible participation in the e-vapor category [17] Other Important Information - The company recorded non-cash impairment charges of $1.3 billion related to e-vapor definite-lived intangible assets and goodwill [23] - The company paid $7 billion in dividends in 2025, marking its 60th increase in the last 56 years [25] - The total debt-to-EBITDA ratio as of December 31 was 2x, in line with the company's target [25] Q&A Session Summary Question: Can you provide any color on the scope of the import/export program? - Management indicated that the program involves both upfront investments and opportunities for duty drawback, setting up manufacturing capabilities for international markets [32] Question: Is the increase in CapEx a one-time increase or a multiyear higher level? - Management confirmed that the increase is primarily driven by investments for the import/export business, but future CapEx guidance was not provided [34] Question: How is the promotional strategy behind Basic affecting net price realization? - Management clarified that the strategy for Basic is independent of the duty drawback and is aimed at capturing consumers under economic pressure [41] Question: What is the strategy for Marlboro given the drop in retail share? - Management emphasized the importance of maximizing profitability while making appropriate investments in Marlboro and growth categories [46] Question: Are there any trends in smoking incidence among younger legal-aged nicotine users? - Management noted that there are no significant trends observed in the data regarding increased smoking incidence among younger cohorts [52] Question: What is the pricing strategy for on! PLUS? - Management believes on! PLUS is a differentiated product that commands a premium in the marketplace, with various introductory price promotions planned [53]

Financial Data and Key Metrics Changes - In 2025, adjusted diluted earnings per share grew by 4.4% and the company returned $8 billion to shareholders through dividends and share repurchases combined [4][24] - The smokable product segment delivered over $11 billion in adjusted operating income (OCI) for the full year, expanding adjusted OCI margins by 1.8 percentage points to 63.4% [16] - For the fourth quarter, adjusted OCI declined by 2.4%, and adjusted OCI margins contracted by 0.8 percentage points to 60.4% [16] Business Line Data and Key Metrics Changes - Domestic cigarette volumes declined by 7.9% in the fourth quarter and 10% for the full year [16] - The oral tobacco product segment retail share was 29.6% for the fourth quarter and 31.9% for the full year [21] - Total segment reported shipment volume decreased 6.3% for the fourth quarter and 5.5% for the full year [21] Market Data and Key Metrics Changes - The estimated number of adult consumers in the e-vapor and oral tobacco categories grew to almost 30 million, reflecting the potential for tobacco harm reduction in the U.S. [6] - The e-vapor category grew approximately 15% in 2025, with illicit products representing approximately 70% of the category [7][8] - The nicotine pouch category grew an estimated 14% over the past six months, with oral nicotine pouches now representing nearly 57% of the total oral category [9] Company Strategy and Development Direction - The company is focused on advancing its smoke-free portfolio and building new pathways for long-term growth in international modern oral and non-nicotine innovations [15] - Strategic investments in retail merchandising and product innovation are planned to support the national launch of on! PLUS in 2026 [12] - The company intends to maintain a measured approach to investments in e-vapor until the regulatory framework is functioning effectively [9] Management's Comments on Operating Environment and Future Outlook - Management noted that the primary driver of industry and smoke-free growth continues to be the widespread availability of illicit flavored, disposable e-vapor products [6] - The company expects to deliver 2026 full year adjusted diluted EPS in a range of $5.56-$5.72, representing a growth rate of 2.5%-5.5% from a $5.42 base in 2025 [14] - Management expressed confidence in the company's strategy and the opportunities ahead, emphasizing the importance of responsible participation in the e-vapor category [15] Other Important Information - The company recorded non-cash impairment charges of $1.3 billion related to e-vapor definite-lived intangible assets and goodwill [22] - The company paid $7 billion in dividends in 2025, marking its 60th increase in the last 56 years [24] Q&A Session Summary Question: Can you provide any color on the scope of the import/export program? - Management indicated that the program involves both upfront investments and the opportunity for duty drawback, setting up manufacturing capabilities for international markets [31] Question: Is the elevated CapEx associated with the investments for import/export a one-time increase? - Management confirmed that the primary driver of the increase is the investments for the import/export business, but they are not guiding for future CapEx [33] Question: How is the promotional strategy behind Basic affecting net price realization? - Management clarified that the strategy around Basic is independent of the duty drawback and is aimed at capturing consumers under economic pressure [40] Question: Are there any signs of increased smoking incidence among younger legal-aged nicotine users? - Management stated that there are no trends indicating increased smoking incidence among younger cohorts, emphasizing the need for expedited product authorizations [50] Question: What is the pricing strategy for on! PLUS? - Management believes on! PLUS is a differentiated product that commands a premium in the marketplace, with various introductory price promotions planned [51]

Core Insights - Altria reported quarterly earnings of $1.3 per share, missing the Zacks Consensus Estimate of $1.32 per share, but showing an increase from $1.29 per share a year ago [1][2] - The company posted revenues of $5.08 billion for the quarter, surpassing the Zacks Consensus Estimate by 1.54%, although this represents a slight decline from $5.11 billion in the previous year [3] Earnings Performance - The earnings surprise for the quarter was -1.13%, contrasting with a positive surprise of +0.69% in the previous quarter [2] - Over the last four quarters, Altria has exceeded consensus EPS estimates three times [2] Stock Performance - Altria shares have increased approximately 9.5% since the beginning of the year, outperforming the S&P 500's gain of 1.9% [4] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [7] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $1.24 on revenues of $4.51 billion, and for the current fiscal year, it is $5.58 on revenues of $20 billion [8] - The outlook for the tobacco industry is currently weak, with the industry ranking in the bottom 32% of over 250 Zacks industries, which may impact Altria's stock performance [9]